Kadowaki, T., Nishida, T., & Kaku, K. (2010). 28‐week, randomized, multicenter, open‐label, parallel‐group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice‐daily injections vs twice‐daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes. Blackwell Publishing Ltd.
Citação norma ChicagoKadowaki, Takashi, Tomoyuki Nishida, and Kohei Kaku. 28‐week, Randomized, Multicenter, Open‐label, Parallel‐group Phase III Trial to Investigate the Efficacy and Safety of Biphasic Insulin Aspart 70 Thrice‐daily Injections Vs Twice‐daily Injections of Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes. Blackwell Publishing Ltd, 2010.
Citação norma MLAKadowaki, Takashi, Tomoyuki Nishida, and Kohei Kaku. 28‐week, Randomized, Multicenter, Open‐label, Parallel‐group Phase III Trial to Investigate the Efficacy and Safety of Biphasic Insulin Aspart 70 Thrice‐daily Injections Vs Twice‐daily Injections of Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes. Blackwell Publishing Ltd, 2010.